Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
18870 | 532 | 45.6 | 92% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
373 | 3 | ENDOGENOUS RETROVIRUS//VIROLOGY//JOURNAL OF VIROLOGY | 32972 |
4146 | 2 | PIM KINASE//PIM 1//PIM 2 | 532 |
18870 | 1 | PIM KINASE//PIM 1//PIM 2 | 532 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | PIM KINASE | authKW | 2314342 | 9% | 81% | 50 |
2 | PIM 1 | authKW | 1750976 | 12% | 49% | 62 |
3 | PIM 2 | authKW | 1322406 | 5% | 96% | 24 |
4 | PIM 1 KINASE | authKW | 1236980 | 5% | 86% | 25 |
5 | PIM 3 | authKW | 1100506 | 4% | 91% | 21 |
6 | PIM1 | authKW | 808306 | 5% | 54% | 26 |
7 | PIM KINASE INHIBITOR | authKW | 351550 | 1% | 88% | 7 |
8 | PIM 1 KINASE INHIBITORS | authKW | 344377 | 1% | 100% | 6 |
9 | CANC MICROENVIRONM PROGRAM | address | 258280 | 1% | 75% | 6 |
10 | SGI 1776 | authKW | 258280 | 1% | 75% | 6 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 2199 | 34% | 0% | 181 |
2 | Cell Biology | 1014 | 23% | 0% | 125 |
3 | Chemistry, Medicinal | 993 | 13% | 0% | 71 |
4 | Biochemistry & Molecular Biology | 582 | 30% | 0% | 160 |
5 | Hematology | 453 | 10% | 0% | 51 |
6 | Genetics & Heredity | 109 | 7% | 0% | 39 |
7 | Medicine, Research & Experimental | 77 | 6% | 0% | 30 |
8 | Chemistry, Organic | 74 | 7% | 0% | 37 |
9 | Biophysics | 37 | 4% | 0% | 22 |
10 | Immunology | 23 | 5% | 0% | 27 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CANC MICROENVIRONM PROGRAM | 258280 | 1% | 75% | 6 |
2 | PANCREAS HEPATOBILIARY | 114792 | 0% | 100% | 2 |
3 | THER EUT PROT DISCOVERY | 114792 | 0% | 100% | 2 |
4 | MOL BIOREGULAT | 83306 | 3% | 10% | 14 |
5 | CANC SHANGHAI CANC | 73792 | 1% | 43% | 3 |
6 | ABO AKAD UNIV | 68584 | 1% | 17% | 7 |
7 | AG HARTMANN | 57396 | 0% | 100% | 1 |
8 | CAN RELATED GENES | 57396 | 0% | 100% | 1 |
9 | CELL MOL BIOL CORE IL | 57396 | 0% | 100% | 1 |
10 | CHAIR CLIN HEMATOL NEOPLAST BLOOD DIS TRANSPL | 57396 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ONCOGENE | 1653 | 4% | 0% | 23 |
2 | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 1627 | 5% | 0% | 27 |
3 | ONCOGENE RESEARCH | 1301 | 0% | 1% | 2 |
4 | ONCOTARGET | 1031 | 3% | 0% | 15 |
5 | BLOOD CANCER JOURNAL | 774 | 0% | 1% | 2 |
6 | MOLECULAR CANCER RESEARCH | 760 | 1% | 0% | 5 |
7 | BLOOD | 707 | 4% | 0% | 21 |
8 | MOLECULAR CANCER THERAPEUTICS | 680 | 1% | 0% | 7 |
9 | ACS MEDICINAL CHEMISTRY LETTERS | 661 | 1% | 0% | 4 |
10 | JOURNAL OF MEDICINAL CHEMISTRY | 431 | 2% | 0% | 13 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PIM KINASE | 2314342 | 9% | 81% | 50 | Search PIM+KINASE | Search PIM+KINASE |
2 | PIM 1 | 1750976 | 12% | 49% | 62 | Search PIM+1 | Search PIM+1 |
3 | PIM 2 | 1322406 | 5% | 96% | 24 | Search PIM+2 | Search PIM+2 |
4 | PIM 1 KINASE | 1236980 | 5% | 86% | 25 | Search PIM+1+KINASE | Search PIM+1+KINASE |
5 | PIM 3 | 1100506 | 4% | 91% | 21 | Search PIM+3 | Search PIM+3 |
6 | PIM1 | 808306 | 5% | 54% | 26 | Search PIM1 | Search PIM1 |
7 | PIM KINASE INHIBITOR | 351550 | 1% | 88% | 7 | Search PIM+KINASE+INHIBITOR | Search PIM+KINASE+INHIBITOR |
8 | PIM 1 KINASE INHIBITORS | 344377 | 1% | 100% | 6 | Search PIM+1+KINASE+INHIBITORS | Search PIM+1+KINASE+INHIBITORS |
9 | SGI 1776 | 258280 | 1% | 75% | 6 | Search SGI+1776 | Search SGI+1776 |
10 | PIM KINASE INHIBITION | 239149 | 1% | 83% | 5 | Search PIM+KINASE+INHIBITION | Search PIM+KINASE+INHIBITION |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | NARLIK-GRASSOW, M , BLANCO-APARICIO, C , CARNERO, A , (2014) THE PIM FAMILY OF SERINE/THREONINE KINASES IN CANCER.MEDICINAL RESEARCH REVIEWS. VOL. 34. ISSUE 1. P. 136-159 | 126 | 81% | 40 |
2 | BLANCO-APARICIO, C , CARNERO, A , (2013) PIM KINASES IN CANCER: DIAGNOSTIC, PROGNOSTIC AND TREATMENT OPPORTUNITIES.BIOCHEMICAL PHARMACOLOGY. VOL. 85. ISSUE 5. P. 629-643 | 118 | 84% | 45 |
3 | BRAULT, L , GASSER, C , BRACHER, F , HUBER, K , KNAPP, S , SCHWALLER, J , (2010) PIM SERINE/THREONINE KINASES IN THE PATHOGENESIS AND THERAPY OF HEMATOLOGIC MALIGNANCIES AND SOLID CANCERS.HAEMATOLOGICA-THE HEMATOLOGY JOURNAL. VOL. 95. ISSUE 6. P. 1004 -1015 | 107 | 76% | 137 |
4 | LE, BT , KUMARASIRI, M , ADAMS, JRJ , YU, MF , MILNE, R , SYKES, MJ , WANG, SD , (2015) TARGETING PIM KINASES FOR CANCER TREATMENT: OPPORTUNITIES AND CHALLENGES.FUTURE MEDICINAL CHEMISTRY. VOL. 7. ISSUE 1. P. 35 -53 | 97 | 87% | 4 |
5 | NAWIJN, MC , ALENDAR, A , BERNS, A , (2011) FOR BETTER OR FOR WORSE: THE ROLE OF PIM ONCOGENES IN TUMORIGENESIS.NATURE REVIEWS CANCER. VOL. 11. ISSUE 1. P. 23 -34 | 102 | 60% | 168 |
6 | ALVARADO, Y , GILES, FJ , SWORDS, RT , (2012) THE PIM KINASES IN HEMATOLOGICAL CANCERS.EXPERT REVIEW OF HEMATOLOGY. VOL. 5. ISSUE 1. P. 81-96 | 105 | 67% | 31 |
7 | MERKEL, AL , MEGGERS, E , OCKER, M , (2012) PIM1 KINASE AS A TARGET FOR CANCER THERAPY.EXPERT OPINION ON INVESTIGATIONAL DRUGS. VOL. 21. ISSUE 4. P. 425 -436 | 81 | 69% | 45 |
8 | WARFEL, NA , KRAFT, AS , (2015) PIM KINASE (AND AKT) BIOLOGY AND SIGNALING IN TUMORS.PHARMACOLOGY & THERAPEUTICS. VOL. 151. ISSUE . P. 41 -49 | 72 | 65% | 17 |
9 | LI, YY , MUKAIDA, N , (2014) PATHOPHYSIOLOGICAL ROLES OF PIM-3 KINASE IN PANCREATIC CANCER DEVELOPMENT AND PROGRESSION.WORLD JOURNAL OF GASTROENTEROLOGY. VOL. 20. ISSUE 28. P. 9392 -9404 | 78 | 73% | 4 |
10 | MAGNUSON, NS , WANG, ZP , DING, G , REEVES, R , (2010) WHY TARGET PIM1 FOR CANCER DIAGNOSIS AND TREATMENT?.FUTURE ONCOLOGY. VOL. 6. ISSUE 9. P. 1461-1478 | 94 | 61% | 44 |
Classes with closest relation at Level 1 |